2021
DOI: 10.1007/s10620-020-06790-6
|View full text |Cite
|
Sign up to set email alerts
|

Hepatic Vein Contrast-Enhanced Ultrasound Subharmonic Imaging Signal as a Screening Test for Portal Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
6
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
6
1

Relationship

1
6

Authors

Journals

citations
Cited by 15 publications
(6 citation statements)
references
References 33 publications
0
6
0
Order By: Relevance
“…However, since the MRI examination time was much longer and the preparation was more difficult and complicated, few patients underwent MRI at the very beginning. A study recruiting 131 patients concluded that contrast-enhanced ultrasonography could discover portal hypertension with a sensitivity and specificity of up to 88% and 63%, respectively [ 77 ]. In 2020, Gupta I et al found that a subharmonic-aided pressure estimation under contrast-enhanced ultrasonography had a relatively satisfactory sensitivity and specificity of 90% and 80% [ 78 ], respectively.…”
Section: Discussionmentioning
confidence: 99%
“…However, since the MRI examination time was much longer and the preparation was more difficult and complicated, few patients underwent MRI at the very beginning. A study recruiting 131 patients concluded that contrast-enhanced ultrasonography could discover portal hypertension with a sensitivity and specificity of up to 88% and 63%, respectively [ 77 ]. In 2020, Gupta I et al found that a subharmonic-aided pressure estimation under contrast-enhanced ultrasonography had a relatively satisfactory sensitivity and specificity of 90% and 80% [ 78 ], respectively.…”
Section: Discussionmentioning
confidence: 99%
“…11,13 More recently, these findings were validated as part of a multi-center clinical trial and also shown to be effective for monitoring progression of portal pressures in patients with chronic liver disease. 14,15,28 in addition, Sonazoid-based SHAPE has been shown to be feasible for the noninvasive measurement of cardiac pressures in both canines and humans. 10,29 Similar translation has been undertaken using SHAPE with Definity (Lantheus Medical Imaging, N Billerica, MA) for cardiac pressure estimation, 16 and for tracking changes in interstitial fluid pressure in breast cancers over the course of neoadjuvant chemotherapy.…”
Section: Discussionmentioning
confidence: 99%
“…Sonazoid was first shown to be useful for the diagnosis of portal hypertension in canine models and in a pilot, human clinical trial 11,13 . More recently, these findings were validated as part of a multi‐center clinical trial and also shown to be effective for monitoring progression of portal pressures in patients with chronic liver disease 14,15,28 . in addition, Sonazoid‐based SHAPE has been shown to be feasible for the noninvasive measurement of cardiac pressures in both canines and humans 10,29 .…”
Section: Discussionmentioning
confidence: 99%
“…In addition, as SHAPE is a quantitative technique based on RF data, the measurements have good reproducibility and reported standard deviations <1 dB. Machado et al 4 conducted a trial with 131 patients (31 subclinical PH and 33 clinical PH), revealing two readers achieved for PH sensitivity of 77%–100%, specificity of 61%–88%, and receiver operating characteristic curve area of 0.70–0.93. The intraobserver reproducibility, assessed by κ value of 0.66.…”
Section: Figurementioning
confidence: 99%